Kerry Expands Irish Facility to Boost Lactose-Free Dairy Production

Kerry, a global leader in taste and nutrition, has expanded its biotechnology manufacturing hub in Ireland. The expansion is aimed at supporting the company's growth in the lactose-free and reduced sugar dairy product sector. The facility is expected to play a crucial role in Kerry's strategy to meet the increasing demand for such products.

The announcement was made by key figures from the company, including Shane McGibney, President and CEO of biotechnology solutions and transformation, and Albert McQuaid, Chief Science and Technology Officer. The expansion will enable Kerry to increase its production capacity and improve its technological capabilities in dairy processing.

This strategic move comes in response to growing consumer demand for healthier dairy options, which has seen a significant rise in recent years. The expanded facility will focus on developing new products that cater to this demand, utilizing advanced biotechnology solutions.

The Irish facility will also house advanced equipment and technologies designed to enhance the production process, ensuring high-quality output. The expansion reflects Kerry's commitment to innovation and sustainability in the dairy industry.

With this development, Kerry aims to strengthen its position in the global dairy market, particularly in the lactose-free and reduced sugar segments. The company is poised to leverage its expanded capabilities to deliver innovative dairy solutions to its customers worldwide.